Amplify Energy Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Amplify Energy Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	365	229	340	276	202	343	458	308	295	263
Cost of revenue					20.5	20.8	29.1	20.8	18.4	17.8
Gross profit					182	322	429	287	276	246
General and administrative	38.7	29.4	43.1	55.3	27.8	25.3	30.2	33	35.9	52.1
Operating expenses	2,009	308	154
Operating income	-1,644	-79.5	81.5	-12	-442	-25.6	72	76.2	30.4	76.9
Interest expense	163	5.59	4.5
Interest income		0.01	0.03
Other non-operating income	-163	-5.58	-24.8	-22.2	-21.5	-6.46	-14	67.6	-15	-16.1
Pre-tax income	-1,807	-85.1	49.8				58	144	15.4	60.8
Income tax	-9.64		0	-0.05	0.12	0	0.11	-249	2.43	16.9
Net income	-1,797	-85.1	54.6	-35.2	-464	-32.1	57.9	393	12.9	44
EBITDA	-1,445	-13.7	134	43.9	-402	2.46	95.9	104	63	109
EPS, basic	-254.67	-3.71	2.09	-1.20	-12.34	-0.84	1.44	9.63	0.31	1.03
EPS, diluted	-254.67	-3.71	2.09	-1.20	-12.34	-0.84	1.44	9.63	0.31	1.03
Shares, basic (weighted)	7.06	23	25	29.3	37.6	38	38.4	39	39.7	40.4
Shares, diluted (weighted)	7.06	23	25	29.3	37.6	38	38.4	39	39.7	40.4

Balance sheet

	FY2015	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	81.1	6.39	49.7	0	10.4	18.8	0	20.7	0	60.7
Receivables	33.7	32.5	29.5	33.1	30.9	92	80.5	39.1	39.7	30.1
Other current assets	1.04	1.51	1.68	13.2	15.6	15	18.8	20.7	25.7	24.4
Total current assets	146	107	106	52.6	56.8	126	99.2	98.2	71.8	131
Property, plant and equipment	524	574	628	804	317	320	339	347	386	189
Lease right-of-use assets			0	4.41	2.5	2.72	7.38	5.76	4.54	3
Other non-current assets	9.5	6.98	6.13	5.84	2.68	1.69	2.24	3.86	2.72	1.37
Total assets	679	688	837	878	385	455	459	738	747	601
Accounts payable	1.9	11.5	2.35	8.31	0.8	33.8	38.4	23.6	13.2	17.9
Accrued liabilities	91.7	42.8	23.2	23.4	22.7	57.8	58.4	50.9	43.4	34.5
Short-term debt	1,891			0
Total current liabilities	1,985	57.8	50.4	61.1	56.9	165	140	96.4	68.1	58.1
Long-term debt		128	294	285	261	230	190	115	127	0
Lease liabilities			0	2.72	0.27	2.02	6.57	5.09	3.68	2.57
Other non-current liabilities	1.97	0.59	0	3.75	3.28	10.7	13	8.12	9.64	9.18
Total liabilities	2,005	294	420	443	418	520	464	347	338	142
Total debt	1,891	128	294	285	261	230	190	115	127	0
Paid-in capital	888	525	356	424	424	425	432	435	440	446
Retained earnings	-2,211	-75.1	55.9	4.81	-463	-495	-437	-44.5	-31.5	12.5
Treasury stock	-3.08	-1.6	-2.46
Shareholders' equity	-1,326	394	417	434	-33.7	-64.8	-4.57	391	409	459
Total equity	-1,326	394	417	434	-33.7	-64.8	-4.57	391	409	459
Total liabilities and equity	679	688	837	878	385	455	459	738	747	601
Shares outstanding	9.93	23	22.2	37.6	37.7	38	38.5	39.1	39.8	40.7

Cash flow statement

	FY2015	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-1,797	-85.1	54.6	-35.2	-464	-32.1	57.9	393	12.9	44
Depreciation and amortization	199	65.8	52.3	55.8	40.3	28.1	24	28	32.6	32.5
Stock-based compensation	4.41	9.2	4.37	4.53	-0.11	1.05	2.96	5.28	6.8	8.29
Deferred income tax	-9.64		0	0	0	0	0	-254	2.2	18.2
Change in receivables	26.4	2.77	5.78	10.7	1.95	-61.2	2.82	41.3	-0.7	8.12
Change in payables	-4.18	2.96	-1.78	-13.6	-9.8	73.7	13.8	-31.5	-24	-5.52
Cash from operations	213	120	142	47.3	74.3	63	64.5	142	51.3	49.2
Cash from investing	-295	-126	23.7	35.3	-35.9	-29.4	-41.5	-38.6	-82	141
Debt issued	625
Share buybacks	-0.49		0	-26.2	0
Dividends paid			0	-15.9	-3.79	0
Cash from financing	151	-1.98	-122	-132	-28.4	-25.1	-41.8	-82.2	10	-130
Net change in cash		-8.34	-57.2	-49.7	10	8.44	-18.8	20.7	-20.7	60.7
Interest paid	161	5.35	17.1	15.9	10.3	8.64	11.2	11	11.7	9.78
Income taxes paid				0	0.09	0	0.09	5.77	1.19	0.13

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.28 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	95.2%	Gross profit / revenue.
Operating margin	19.9%	Operating income / revenue.
EBITDA margin	31.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	15.7%	Pre-tax income / revenue.
Net margin	10.6%	Net income / revenue.
Operating cash flow margin	3.4%	Cash from operations / revenue.
Return on equity (ROE)	5.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.9%	Net income / average total assets.
Return on invested capital (ROIC)	8.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	3.6%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	11.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-16.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-11.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-17.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	152.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	2.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	73.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	4.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	239.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-8.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	232.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-10.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-4.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-8.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-7.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.2%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-19.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	9.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	9.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.31x	Current assets / current liabilities.
Quick ratio	0.81x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.42x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	23.8%	Total liabilities / total assets.
Working capital	$15.4M	Current assets - current liabilities.
Tangible book value	$439.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.37x	Revenue / average total assets.
Fixed asset turnover	0.97x	Revenue / average property, plant and equipment.
Receivables turnover	10.9x	Revenue / average receivables.
Days sales outstanding	33 days	365 x average receivables / revenue.
Days payables	787 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.55	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$5.16	Revenue / diluted weighted shares.
Operating cash flow per share	$0.18	Cash from operations / diluted weighted shares.
Book value per share	$10.63	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$10.63	Tangible book value / shares outstanding.
Cash per share	$0.51	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$177.4M	Share price x shares outstanding.
Enterprise value	$156.2M	Market cap + total debt - cash - short-term investments.
P/E	7.84x	Market cap / net income. Only when net income is positive.
P/S	0.83x	Market cap / revenue.
P/B	0.40x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.40x	Market cap / tangible book value, when positive.
P/OCF	24.2x	Market cap / cash from operations, when positive.
EV/Sales	0.73x	Enterprise value / revenue.
EV/EBIT	3.69x	Enterprise value / operating income, when both are positive.
EV/EBITDA	2.33x	Enterprise value / EBITDA, when both are positive.
Earnings yield	12.8%	Net income / market cap (the inverse of P/E).

What was Amplify Energy Corp.'s revenue in fiscal 2025?

Amplify Energy Corp. reported revenue of $263.4M for fiscal 2025, 10.6% lower than the year before.

Was Amplify Energy Corp. profitable in fiscal 2025?

Yes. Net income was $44.0M, a net margin of 16.7%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Amplify Energy Corp.